Two main methods have been proposed in relation to bladder ART ... 48% of patients received neoadjuvant or adjuvant radiotherapy and/or chemotherapy. § 24% of patients received postoperative ...

Standard treatment for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by ... Previous trials of neoadjuvant and adjuvant immunotherapy showed clinical benefit in this setting ...

“We are disappointed in the ADJUVANT BR.31 results ... NIAGARA compared Imfinzi plus chemo to chemo alone in muscle-invasive bladder cancer (MIBC) patients scheduled for a cystectomy to ...

For example, oncologists don’t usually recommend adjuvant chemotherapy for most people with stage 2 colorectal cancer unless ...

Intravesical bacillus Calmette-Guerin (tuberculosis vaccine) has been used as adjuvant therapy by urologists ... Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as ...

“The medical term for preventative chemotherapy is adjuvant chemotherapy.” However, preventative chemotherapy should not be confused with cancer prevention—medical and lifestyle decisions aimed at ...

MSD presented positive data for its PD-1 drug Keytruda (pembrolizumab) for adjuvant ... of Barts Cancer Centre in London, UK, pointed out that neoadjuvant chemotherapy and bladder removal have ...

A multigene signature can be used to guide decisions about adjuvant therapy in patients with triple-negative breast cancer, data suggest.

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

The partners are also studying their personalized vaccine with Keytruda as an adjuvant NSCLC treatment for those who haven't gotten neoadjuvant therapy.

Anteriorly, the field extends 1.5–2 cm beyond the bladder and posteriorly ... 48% of patients received neoadjuvant or adjuvant radiotherapy and/or chemotherapy. § 24% of patients received ...